Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial

Por Wade, A. J., Doyle, J. S., Gane, E., Stedman, C., Draper, B., Iser, D., Roberts, S. K., Kemp, W., Petrie, D., Scott, N., Higgs, P., Agius, P. A., Roney, J., Stothers, L., Thompson, A. J., Hellard, M. E.
Publicado no Trials (2018)

Incidence Differences Between First Primary Cancers and Second Primary Cancers Following Skin Squamous Cell Carcinoma as Etiological Clues

Por Zheng G, Sundquist K, Sundquist J, Försti A, Hemminki A, Hemminki K
Publicado em 2020-08-01

New direct-acting antivirals in the development for hepatitis C virus infection

Por Pockros, Paul J.
Publicado em 2010

Development and Preliminary Validation of Diabetes Adjustment Assessment Scale (DAAS): a New Measure of Adjustment with Type 2 Diabetes

Por Ebrahimi, Hossein, Karimi Moonaghi, Hossein, Asghari Jafarabadi, Mohammad, Namdar Areshtanab, Hossein, Jouybari, Leila
Publicado no J Caring Sci (2016)

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0

Por Ryom, L, Boesecke, C, Bracchi, M, Ambrosioni, J, Pozniak, A, Arribas, J, Behrens, G, Mallon, PGM, Puoti, M, Rauch, A, Miro, JM, Kirk, O, Marzolini, C, Lundgren, JD, Battegay, M
Publicado no HIV Med (2018)

Psychosocial assessment and monitoring in the new era of non-interferon-alpha hepatitis C virus treatments

Por Rowan, Paul J, Bhulani, Nizar
Publicado no World J Hepatol (2015)

Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new...

Por Aebi-Popp, Karoline, Duppenthaler, Andrea, Rauch, Andri, De Gottardi, Andrea, Kahlert, Christian
Publicado no J Virus Erad (2016)

Maximizing Opportunities and Avoiding Mistakes in Triple Therapy for Hepatitis C Virus

Por Barritt, A. Sidney, Fried, Michael W.
Publicado em 2012

Drug–drug interactions during antiviral therapy for chronic hepatitis C

Por Kiser, Jennifer J., Burton, James R., Everson, Gregory T.
Publicado no Nat Rev Gastroenterol Hepatol (2013)

Successful Anti-HCV Therapy of a Former Intravenous Drug User with Sofosbuvir and Daclatasvir in a Peritranspant Setting: A Case Report

Por Seifert, Leon Louis, Heinzow, Hauke, Kabar, Iyad, Christensen, Stefan, Hüsing, Anna, Schmidt, Hartmut H.-J.
Publicado no Am J Case Rep (2016)

HIV care and treatment clinic performance following President’s Emergency Plan for AIDS Relief-funded infrastructure improvement in Tanzania

Por Boniphace M. Idindili, Simon J. King, Kristen Stolka, Irene Mashasi, Philberth Bashosho, Happy Karungula, Florida Chintowa, Godfrey Mwakabole, Kimberly Ashburn, Barbara Do, Norman Goco
Publicado em 2018-06-01

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?

Por Grebely, Jason, Dore, Gregory J., Morin, Sébastien, Rockstroh, Jürgen K., Klein, Marina B.
Publicado no J Int AIDS Soc (2017)

Treatment strategies for chronic hepatitis C prior to and following liver transplantation

Por Perumpail, Ryan B, Hahambis, Thomas A, Aggarwal, Avin, Younossi, Zobair M, Ahmed, Aijaz
Publicado no World J Hepatol (2016)

The Presence of GAD and IA-2 Antibodies in Youth With a Type 2 Diabetes Phenotype: Results from the TODAY study

Por Klingensmith, Georgeanna J., Pyle, Laura, Arslanian, Silva, Copeland, Kenneth C., Cuttler, Leona, Kaufman, Francine, Laffel, Lori, Marcovina, Santica, Tollefsen, Sherida E., Weinstock, Ruth S., Linder, Barbara
Publicado em 2010

Small Molecules Targeting Hepatitis C Virus-Encoded NS5A Cause Subcellular Redistribution of Their Target: Insights into Compound Modes of Action

Por Targett-Adams, Paul, Graham, Emily J. S., Middleton, Jenny, Palmer, Amy, Shaw, Stephen M., Lavender, Helen, Brain, Philip, Tran, Thien Duc, Jones, Lyn H., Wakenhut, Florian, Stammen, Blanda, Pryde, David, Pickford, Chris, Westby, Mike
Publicado em 2011

Hepatitis C virus cures after direct acting antiviral-related drug-induced liver injury: Case report

Por Hasin, Yaakov, Shteingart, Shimon, Dahari, Harel, Gafanovich, Inna, Floru, Sharon, Braun, Marius, Shlomai, Amir, Verstandig, Anthony, Dery, Ilana, Uprichard, Susan L, Cotler, Scott J, Lurie, Yoav
Publicado no World J Hepatol (2016)

New treatments for chronic hepatitis C: An overview for paediatricians

Por Serranti, Daniele, Indolfi, Giuseppe, Resti, Massimo
Publicado no World J Gastroenterol (2014)

Impact of new treatment options for hepatitis C virus infection in liver transplantation

Por Righi, Elda, Londero, Angela, Carnelutti, Alessia, Baccarani, Umberto, Bassetti, Matteo
Publicado no World J Gastroenterol (2015)

Prevalence and Risk Factors for Sexually Transmitted Infections in Gay and Bisexual Prostate Cancer Survivors: Results From the Restore-2 Study

Por Christopher W. Wheldon, Elizabeth Polter, B. R. Simon Rosser, Alex J. Bates, Ryan Haggart, Morgan Wright, Darryl Mitteldorf, Michael W. Ross, Badrinath R. Konety, Nidhi Kohli, Kristine M. C. Talley, William West, Alexander K. Tatum
Publicado em 2022-05-01

Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis C

Por Avisar, Nitzan, Heller, Yael, Weil, Clara, Ben-Baruch, Aviva, Potesman-Yona, Shani, Oren, Ran, Chodick, Gabriel, Shalev, Varda, Ash, Nachman
Publicado no Isr J Health Policy Res (2017)